Peggy Wentworth

Title: Peggy Wentworth: Innovator in Ex Vivo Therapy

Introduction

Peggy Wentworth is a notable inventor based in San Diego, CA. She has made significant contributions to the field of immunotherapy, particularly through her innovative patent related to ex vivo therapy. Her work focuses on enhancing the activation of cytotoxic T lymphocytes (CTL), which are crucial for effective cancer treatment.

Latest Patents

Peggy Wentworth holds a patent titled "Methods for ex vivo therapy using peptide-loaded antigen presenting." This patent presents methods for activating CTLs in vitro, which are then utilized for therapy in vivo. Additionally, it describes a method for selectively killing specific CTLs in vivo using antigen presenting cells that have been modified in vitro. This innovative approach has the potential to improve therapeutic outcomes for patients.

Career Highlights

Peggy is currently associated with Cytel Corporation, where she applies her expertise in immunotherapy. Her work at Cytel has allowed her to collaborate with other talented professionals in the field, contributing to advancements in cancer treatment methodologies.

Collaborations

Throughout her career, Peggy has worked alongside esteemed colleagues such as Esteban Celis and Ralph T Kubo. These collaborations have fostered a dynamic environment for innovation and research, further enhancing the impact of her work.

Conclusion

Peggy Wentworth's contributions to ex vivo therapy exemplify her dedication to advancing medical science. Her innovative patent and collaborative efforts position her as a key figure in the field of immunotherapy.